SEARCH

SEARCH BY CITATION

References

  • 1
    WHO. Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO, 2003-2011. Available: http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/ (Accessed 12 April 2012).
  • 2
    Tran TH, Nguywen TL, Nguyen TD et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350:11791188.
  • 3
    Chotpitayasunondh T, Ungchusak K, Hanshaoworaku W et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005; 11:201209.
  • 4
    Tran TH, Nguyen TL, Nguyen TD et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350:11791188.
  • 5
    Szretter KJ, Gangappa S, Lu X et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007; 81:27362744.
  • 6
    Hers JFP, Mulder J, Masurel N, Kuip LVD, Tyrrell DAJ. Studies on the pathogenesis of influenza virus pneumonia in mice. J Pathol Bacteriol 1962; 83:707717.
  • 7
    Loosli CG, Buckly RD, Hardy JD et al. The pathogenesis of postinfluenzal collapse of the lungs of mice. Trans Assoc Am Physicians 1971; 84:182189.
  • 8
    Raut S, Hurd J, Cureton RJ, Blandford G, Heath RB. The pathogenesis of infections of the mouse caused by virulent and avirulent variations of an influenza virus. J Med Microbiol 1975; 8:127136.
  • 9
    Wyde PR, Couch RB, Mackler BF, Cate TR, Levy BM. Effects of low-and high-passage influenza virus infection virus infection in normal and nude mice. Infect Immun 1977; 15:221229.
  • 10
    Oda T, Akaike T, Hamamoto T et al. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 1989; 244:974976.
  • 11
    Akaike T, Ando M, Oda T et al. Dependence on O2˙- generation by Xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest 1990; 85:739745.
  • 12
    Requena JR, Fu MX, Ahmed MU, Jenkins AJ, Lyons TJ, Thorpe SR. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol Dial Transplant 1996; 11(Suppl. 5):4853.
  • 13
    Suliman HB, Ryan LK, Bishop L, Folz RJ. Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase. Am J Physiol Lung Cell Mol Physiol 2001; 280:L69L78.
  • 14
    Tate RM, Repine JE. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 1983; 128:552559.
  • 15
    Maeda H, Akaike T. Oxygen free radicals as pathogenic molecules in viral diseases. Proc Soc Exp Biol Med 1991; 198:721727.
  • 16
    Xu T, Qiao J, Zhao LH et al. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am J Respir Care Med 2006; 174:10111017.
  • 17
    Gui X, Yang P, Qiu Y, Liu J, Zou G. Studies on the preparation and the stability of SOD modified by lauric acid. Wuhan University J Nat Sci 1998; 3:247250.
  • 18
    Sidwell RW, Huffman JH, Bailey KW et al. Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infection in mice. Antimicrob Agents Chemother 1996; 40:26262631.
  • 19
    Xu T, Qiao J, Zhao LH et al. Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice. Eur Respir J 2009; 33:850860.
  • 20
    Cao Y, Guo P, Xu YC, Zhao B. Simultaneous detection of NO and ROS by ESR in biological systems. Methods Enzymol 2005; 396:7783.
  • 21
    Reinke LA, Lai EK, DuBose CM, McCay PB. Reactive free radicals generation in vivo in heart and liver of ethanol-fed rats: correlation with radical formation in vitro. Proc Natl Acad Sci 1987; 84:92239227.
  • 22
    Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34:479500.
  • 23
    Hermann E, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186:407421.
  • 24
    Price GE, Gaszewska-Mastarlarz A, Moskophidis D. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice. J Virol 2000; 74:39964003.
  • 25
    Reed LJ, Muench H. Simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27:493497.
  • 26
    Uiprasertkul MP, Puthavathana K, Sangsiriwut P et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis 2005; 11:10361041.
  • 27
    Slemmer JE, Shacka JJ, Sweeney MI, Weber JT. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr Med Chem 2008; 15:404414.
  • 28
    Rao AV, Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 2002; 5:291309.
  • 29
    Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90:79157922.
  • 30
    Chan MCW, Cheung CY, Chui WH et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005; 6:135.
  • 31
    Monto AS. The role of antivirals in the control of influenza. Vaccine 2003; 21:17961800.
  • 32
    Guan Y, Chen H. Resistance to anti-influenza agents. Lancet 2005; 366:11391140.
  • 33
    Fleming DM. Zanamivir in the treatment of influenza. Expert Opin Pharmacother 2003; 4:799805.
  • 34
    Uchide N, Toyoda H. Potential of selected antioxidants for influenza chemotherapy. Anti-Infect Agents Med Chem 2008; 7:7383.
  • 35
    Uchide N, Toyoda H. Future target molecules for influenza treatment. Mini-Rev Med Chem 2008; 8:491495.